EPA Stops Counting Lives Saved by Clean Air Rules—Here's Why Health Experts Are Alarmed

The Environmental Protection Agency has stopped calculating the economic value of lives saved and health problems prevented by air pollution rules, marking a dramatic reversal from decades of practice. Instead of weighing the health benefits against industry costs, the EPA now says there is too much uncertainty to assign dollar amounts to the lives protected by cleaner air standards.

What Changed at the EPA?

For over 40 years, the EPA has used a straightforward approach: estimate how much it costs industry to comply with pollution rules, then calculate how much money Americans save through avoided health problems and longer lives. A 1981 executive order from President Ronald Reagan required federal agencies to weigh both costs and benefits of major regulations like the Clean Air Act.

The EPA developed sophisticated methods to estimate these benefits. Researchers would calculate how many lives would be saved, how many asthma attacks prevented, and how many heart attacks avoided—then translate those into dollar amounts. The results were striking: the Clean Air Act typically showed benefit-to-cost ratios of 30 to 1 or higher, meaning every dollar spent on pollution control saved Americans roughly 30 dollars in health care costs and lost productivity.

Now, the EPA has stopped this practice for two major air pollutants: fine particles (PM2.5, sometimes called soot) and ozone. The agency published this change in a new rule that also weakened air pollution standards for power plant turbines that burn fossil fuels.

Why Does Removing Dollar Values Matter?

On the surface, the EPA's explanation sounds reasonable: there is uncertainty in health benefit estimates, so the agency will pause assigning dollar values until it reconsiders its methods. But environmental law experts warn this creates a dangerous imbalance in how regulations are evaluated.

"It looks good only because you ignore the main consequence of the rollback, which is the additional negative impact on public health," explains Richard Revesz, an environmental law expert at New York University. "By just saying we are assuming no harm doesn't mean there is no harm".

Here's the problem: industry costs are still calculated in concrete dollar amounts. If a power plant must spend 100 million dollars to upgrade equipment, that number appears in the regulatory analysis. But if the health benefits—preventing thousands of deaths and illnesses—have no assigned dollar value, they become invisible in the cost-benefit comparison. It becomes easier for regulators to justify rolling back protections.

What Health Risks Are at Stake?

The health consequences of fine particle pollution are well-established by decades of research. Long-term exposure to PM2.5 causes a range of serious conditions, including higher rates of asthma, more heart attacks, dementia, and premature death.

The landmark Harvard University Six Cities study, which ran from the 1970s until the 1990s, showed unambiguously that living in more polluted areas shortened people's lives. Since then, hundreds of research analyses—including many produced by EPA scientists themselves—have linked fine particle pollution to damage in people's lungs, hearts, and brains.

Recent estimates suggest the scale of protection at stake. Cleaning up pollution from fine particles has, by the EPA's previous calculations, saved more than 230,000 lives and billions of dollars per year in recent years.

The real-world evidence is striking. After a polluting coke plant closed in Pennsylvania, cardiovascular and respiratory problems dropped dramatically in the surrounding population—showing that reducing pollution can have near-instantaneous health benefits.

Who Is Most Vulnerable?

Certain groups face heightened risks from air pollution. Mary Rice, a pulmonologist and air pollution expert at Harvard University and director of Harvard's Center for Climate Health and the Global Environment, identifies the most vulnerable populations.

"I'm worried about what this could mean for health," says Dr. Rice. "Especially for people with chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD), for kids whose lungs are still developing, and for older people, who are especially susceptible to the harmful effects of air pollution on the heart, lungs and the brain".

Children's developing lungs, older adults with existing heart and lung conditions, and people with chronic respiratory diseases all face disproportionate harm from fine particle pollution. This means any rollback in air quality standards could have the largest impact on the most vulnerable Americans.

Steps to Understand How This Affects You

• Check Your Local Air Quality: Monitor your area's air quality index (AQI) regularly, especially if you have asthma, COPD, or heart disease. Higher pollution days mean increased health risks for vulnerable groups.
• Know Your Risk Factors: If you are a child, older adult, or have chronic respiratory or heart conditions, you are at higher risk from fine particle pollution and should take extra precautions on high-pollution days.
• Stay Informed on Policy Changes: Follow EPA regulatory announcements and air quality standards in your state, as federal rollbacks could affect local pollution levels and your long-term health exposure.
• Advocate for Clean Air Standards: Contact elected representatives about the importance of maintaining strong air pollution protections, especially if you live near power plants or industrial facilities.

Is This a Legal Problem?

Legally, the EPA's move exists in a gray area. A 2014 U.S. Supreme Court case clarified that agencies like the EPA must consider both benefits and costs in their regulatory processes. However, the courts have not specified exactly how agencies must do this.

"So, yes, they do have to consider both, but there is no legally enforceable requirement for them to do it in any particular way," explains Jeffrey Holmstead, an EPA expert and lawyer at Bracewell, LLC and former leader of the EPA's Office of Air and Radiation during the George W. Bush administration.

This leaves discretion to the EPA. The agency can assess health benefits without assigning a specific dollar value—some EPA regulations on hazardous air pollutants already do this. However, experts argue that sophisticated cost-benefit analysis requires monetizing both sides of the equation.

"You can't do a sophisticated cost-benefit analysis without trying to monetize both the costs and the benefits," Holmstead notes. "This will be the first time in a long time that EPA hasn't tried to provide a monetary benefit to reducing at least PM 2.5 and ozone".

Part of a Broader Pattern?

This change is not isolated. The EPA has made similar moves in other regulatory areas under the Trump administration. In its proposal to roll back vehicle emissions standards, the EPA did not assess potential economic benefits to consumers who switched to electric vehicles instead of gas-powered cars. It also explicitly declined to calculate societal economic benefits of reducing greenhouse gas emissions and significantly lowered estimates of health savings from tighter rules.

The EPA made the same moves in efforts to roll back the endangerment finding—a determination in place since 2009 concluding that greenhouse gas buildup in the atmosphere poses serious risks to public health and well-being.

Together, these changes represent a fundamental shift in how the EPA weighs human health against industry costs. Health experts and environmental lawyers describe the approach as extraordinarily unusual and potentially dangerous for millions of Americans breathing the air in their communities.